Objective: The proposed study aims to develop a protocol of telephone-based Acceptance and Commitment Therapy (ACT) for Alcohol Use Disorder (AUD) and examine the feasibility of implementing such intervention among the Hong Kong Chinese young adults with AUD. Study design: A randomized controlled trial will be carried out. A convenience sample of 60 young adults with AUD will be recruited from the community. Subjects who are randomized into the experimental group which will receive a total of 6 weekly telephone-based ACT provided by an experienced health counsellor, or into the control group which will receive social support provided by a research assistant, that mimics the time and attention of the intervention. Feasibility measures will be collected at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups. Also, all subjects will be asked to complete a structured questionnaire to assess their alcohol use behaviours and psychological flexibility at the same time points. Main outcome measures: The primary outcomes are feasibility measures by descriptive statistics. The secondary outcome is the preliminary effectiveness of telephone-based ACT in alcohol abstinence at 6 months Data analysis: Multiple logistic regression will be used for analysis. Intention-to-treat analysis will be applied. Multiple imputations will be used to handle the missing data.
Age range
18 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Screening rate
Timeframe: Baseline
Eligibility rate
Timeframe: Baseline
Consent rate
Timeframe: Baseline
Randomization rate
Timeframe: Baseline
Attendance rate to the intervention
Timeframe: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Adherence to intervention
Timeframe: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Retention rate
Timeframe: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Completion rate
Timeframe: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Missing data
Timeframe: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Adverse event
Timeframe: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups